GHK-Cu is a copper-binding tripeptide used in laboratory research to study peptide-copper interactions, signaling pathways, and gene-expression responses in controlled experimental systems
Supports firmness, recovery, renewal and smoother skin
Methods and materials Reagents Pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W.1419) was synthesized by Kelowna International Scientific Inc
Analytical Method & Instrumentation Method:ICP-MS per ICH Q3D(R2) / USP / ChP 0412 Instrument:Agilent 7900 ICP-MS (SN: JP93181) with He collision mode Sample Prep:Closed-vessel microwave digestion (CEM MARS 6): 34.4 mg + 5mL HNO(suprapure) + 1mL HO (30%) Digestion:Ramp 20min 200C, hold 15min, cool to RT, dilute to 50.0 mL (Milli-Q, 18.2 Mcm) Calibration:Multi-element std (NIST SRM 3100 series), 5-point external cal
reserve lisdexamfetamine for persistent binge patterns after foundational supports
Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection